Cargando…
Does tranexamic acid decrease bleeding in patients undergoing cardiopulmonary bypass?
We reviewed the records of 66 patients who underwent cardiopulmonary bypass; half of these patients received the plasmin inhibitor, tranexamic acid. The demographics were not different between the group who received tranexamic acid and the group who did not (control group). There was no difference i...
Autores principales: | Connelly, N. R., Kiessling, B. M., Brull, S. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588904/ https://www.ncbi.nlm.nih.gov/pubmed/8579642 |
Ejemplares similares
-
Postoperative dose of tranexamic acid decreases postoperative bleeding and inflammatory response associated with cardiopulmonary bypass: a randomized, double-blind study
por: Brouard, M, et al.
Publicado: (2008) -
Does topical tranexamic acid reduce postcoronary artery bypass graft bleeding?
por: Mirmohammadsadeghi, Amir, et al.
Publicado: (2018) -
Tranexamic acid effects on postoperative bleeding in cardiopulmonary bypass surgery according to the plasminogen activator inhibitor-1 polymorphism
por: Brouard, M, et al.
Publicado: (2008) -
Comparison of intraoperative tranexamic acid and epsilon-aminocaproic acid in cardiopulmonary bypass patients
por: Broadwin, Mark, et al.
Publicado: (2020) -
Tranexamic acid decreased postoperative bleeding and systemic inflammatory response syndrome associated with cardiopulmonary bypass: a prospective, randomized, double-blind controlled study
por: Jimenez Rivera, J, et al.
Publicado: (2006)